Artificial intelligence can help analyse research, review code and identify patterns. But its value in healthcare will depend on the judgment of those using it, Deputy Research Minister Nicodemos Damianou said at a graduation ceremony at the Cyprus Institute of Neurology and Genetics (CING).
“I hope it helped. I also hope you checked its answer,”
Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram
he told graduates.
Seventy students received master’s and doctoral degrees, bringing CING’s alumni total to 462. Damianou outlined Cyprus’ plans to integrate AI into healthcare, including medical imaging, diagnostics and personalised treatment.
AI And Healthcare Research
Healthcare and life sciences are among the priority sectors for AI adoption under Cyprus’ National AI Strategy 2032. The strategy also focuses on bioinformatics, health data infrastructure and testing new technologies under appropriate safeguards.
CING, which already serves as a research centre for rare diseases, could develop a dedicated AI testing environment in collaboration with other research organisations and biotechnology companies, Damianou said.
Founded in 1990, the institute serves approximately 6,500 patients annually and provides more than 80,000 clinical and laboratory services. Its research has contributed to potential treatments for inherited peripheral neuropathies, thalassaemia and myotonic dystrophy.
In July, CING opened a new building following a €31 million investment supported by the government and the European Investment Bank. Damianou described the project as a sign of confidence in the institute’s achievements and future.
Building Cyprus’ Research Capabilities
Research and innovation are central to Cyprus’ ambition to become a regional technology hub. Institutions such as CING can help retain local talent and attract professionals returning from abroad, supporting the government’s Minds in Cyprus programme.
Damianou also highlighted the institute’s forthcoming physiotherapy centre and its role in rehabilitation and improving patients’ quality of life.
Why Human Judgment Matters
AI is changing how scientists analyse data, study diseases and investigate potential treatments. However, Damianou said researchers must remain able to question results, recognise limitations and understand the consequences of their discoveries.
He cited Nobel laureate Katalin Kariko, whose research faced repeated rejection before a chance conversation with immunologist Drew Weissman in 1997 led to a collaboration that helped make mRNA vaccines possible. The pair received the 2023 Nobel Prize in Physiology or Medicine.
Damianou encouraged graduates to remain curious, work across disciplines and be open to unexpected opportunities.
As AI becomes more capable, he said, integrity, empathy and scientific judgment will become increasingly important. He urged graduates to measure success by “the problems you helped solve, the people you helped and the opportunities you created for others”.







